Host Immune Response to Novel RNA COVID-19 Vaccination
NCT04784689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-05-25
Summary
To determine the antibody response level in patients with cancer to the COVID-19 vaccination.
Conditions
Interventions
- BIOLOGICAL
-
COVID-19 Vaccine
Sponsors & Collaborators
-
The University of Texas Health Science Center at San Antonio
lead OTHER
Principal Investigators
-
Dimpy Shah, MD PhD · University of Texas Health Science Center San Antonio
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-24
- Primary Completion
- 2022-05-18
- Completion
- 2022-05-18
Countries
- United States
Study Locations
More Related Trials
-
Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
NCT05062525 ·Status: COMPLETED
-
Responses to COVID-19 Vaccination in Patients With Cancer
NCT04745377 ·Status: COMPLETED
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment
NCT05119738 ·Status: UNKNOWN
-
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
NCT04858607 ·Status: COMPLETED
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients
NCT05313074 ·Status: COMPLETED ·Phase: NA
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
NCT04871165 ·Status: UNKNOWN
-
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
NCT04743388 ·Status: UNKNOWN
-
COVID-19 Antibody Levels After Vaccines
NCT04944134 ·Status: COMPLETED
-
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
NCT04742595 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Immunosuppression and COVID-19 Boosters
NCT05415267 ·Status: RECRUITING ·Phase: PHASE3
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
NCT04948619 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
NCT05164016 ·Status: COMPLETED
-
The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
NCT05132855 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
NCT05228275 ·Status: ACTIVE_NOT_RECRUITING
-
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
NCT04878822 ·Status: UNKNOWN
-
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
NCT04442048 ·Status: COMPLETED ·Phase: PHASE3
-
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
NCT04830046 ·Status: COMPLETED
-
Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer
NCT02018458 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
NCT02318394 ·Status: COMPLETED ·Phase: PHASE1
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Immuno-Oncology Database and Bioregistry
NCT04656873 ·Status: ACTIVE_NOT_RECRUITING